Targeting of BMI-1 with PTC-209 inhibits glioblastoma development

Glioblastoma multiforme (GBM) is the most common and aggressive brain tumor and refractory to existing therapies. The oncogene BMI-1, a member of Polycomb Repressive Complex 1 (PRC1) plays essential roles in various human cancers and becomes an attractive therapeutic target. Here we showed that BMI-...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cell Cycle
Главные авторы: Kong, Yu, Ai, Chunbo, Dong, Feng, Xia, Xianyou, Zhao, Xiujuan, Yang, Chao, Kang, Chunsheng, Zhou, Yan, Zhao, Qian, Sun, Xiujing, Wu, Xudong
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2018
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6110607/
https://ncbi.nlm.nih.gov/pubmed/29886801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2018.1469872
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы